Potential of IRMS technology for tracing gamma-butyrolactone (GBL)

Forensic Science International

Volumn 198, Issue 1-3, 2010, Pages 46-52

  Marclay, François ^a   Pazos, Diego ^b   Delémont, Olivier ^b   Esseiva, Pierre ^b   Saudan, Christophe ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Drug of abuse; Gamma butyrolactone; Gamma hydroxy butyric acid; Isotope ratio mass spectrometry

Indexed keywords

CARBON; CARBON 13; GAMMA BUTYROLACTONE;

ACCURACY; ARTICLE; COMBUSTION; CONTROLLED STUDY; DISTILLATION; GAS CHROMATOGRAPHY; ISOTOPE ANALYSIS; ISOTOPE RATIO MASS SPECTROMETRY; MASS SPECTROMETRY; PRIORITY JOURNAL; PURIFICATION; REPRODUCIBILITY;

EID: 77952292322     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.12.014     Document Type: Article

References (40)

1. Morgan M.L. The rapidly changing world of 1,4-butanediol. Chem. Ind. 1997, 3:166-168.
2. Couper F.J., Marinetti L.J. γ-Hydroxybutyrate (GHB)-effects on human performance and behavior. Forensic Sci. Rev. 2002, 14:102-121. Available at: http://www.ndaa.org/pdf/ntlc_ghb.pdf (accessed June 18.06.09).
3. China Chemical Reporter, GBL will be oversupply, Market Report: polymer, November 6, 2006.
4. Kyrides L.P., Zienty F.B. Dehydrogenation of 1,4-pentanediol. J. Am. Chem. Soc. 1946, 68:1385.
5. Ichikawa N., Sato S., Takahashi R., Sodesawa T., Inui K. Dehydrogenative cyclization of 1,4-butanediol over copper-based catalyst. J. Mol. Catal. A: Chem. 2004, 212:197-203.
6. 2 as high efficient catalyst for the selective oxidative cyclization of 1,4-butanediol to γ-butyrolactone. J. Catal. 2007, 252:69-76.
7. Haas T., Jaeger B., Weber R., Mitchell S.F., King C.F. New diol processes: 1,3-propanediol and 1,4-butanediol. Appl. Catal. A: Gen. 2005, 280:83-85.
8. Ohlinger C., Kraushaar-Czarnetzki B. Improved processing stability in the hydrogenation of dimethyl maleate to γ-butyrolactone, 1,4-butanediol and tetrahydrofuran. Chem. Eng. Sci. 2003, 58:1453-1461.
9. Hara Y., Kusaka H., Inagaki H., Takahashi K., Wada K. A novel production of γ-butyrolactone catalyzed by ruthenium complexes. J. Catal. 2000, 194:188-197.
10. Zhu Y.-L., Yang J., Dong G.-Q., Zheng H.-Y., Zhang H.-H., Xiang H.-W., Li Y.-W. An environmentally benign route to γ-butyrolactone through the coupling of hydrogenation and dehydrogenation, A. Catal. B: Environ. 2005, 57:183-190.
11. Castiglioni G.L., Ferrari M., Guercio A., Vaccari A., Lancia R., Fumagalli C. Chromium-free catalysts for selective vapor phase hydrogenation of maleic anhydre to γ-butyrolactone. Catal. Today 1996, 27:181-186.
12. Berkowitz L.M., Rylande P.N. Use of ruthenium tetroxide as a multi-purpose oxidant. J. Am. Chem. Soc. 1958, 80:6682-6684.
13. GHB and Its Precursor GBL: An Emerging Trend Case Study 2008, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.
14. Sjöqvist F., Garle M., Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008, 371:1872-1882.
15. Liechti M.E, Kupferschmidt H. γ-Hydroxybutyrate (GHB) and γ-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre. Swiss Med. Wkly 2004, 134:534-537.
16. Roth R.H., Giarman N.J. Evidence that central nervous system depression by 1,4-butanediol is mediated through a metabolite, gamma-hydroxybutyrate. Biochem. Pharmacol. 1968, 17:735-739.
17. Roth R.H., Giarman N.J. Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochem. Pharmacol. 1970, 19:1087-1093.
18. Lenz D., Rothschild M.A., Kröner L. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone. Ther. Drug Monit. 2008, 30:755-761.
19. Mickelsson K. Gamma-butyrolactone (GBL) and 1,4-Butanediol (1,4-BD) as Industrial Chemicals and Drugs of Abuse, Can They be Regulated? 2005, National Institute of Public Health, http://www.fhi.se (accessed 24.06.09).
20. Benson S., Lennard C., Maynard P., Roux C. Forensic applications of isotope ratio mass spectrometry-a review. Forensic Sci. Int. 2006, 157:1-22.
21. Craig H. Isotopic standards for carbon and oxygen and correction factors for mass-spectrometric analysis of carbon dioxide. Geochim. Cosmochim. Acta 1957, 12:133-149.
22. WADA Technical Document-TD2003IDCR 2007, World Anti-Doping Agency, http://www.wada-ama.org/rtecontent/document/criteria_1_2.pdf (accessed 26.08.07).
23. Fawcett T. An introduction to ROC analysis. Pattern Recogn. Lett. 2006, 27(8):861-874.
24. Esseiva P., Ioset S., Anglada F., Gasté L., Ribaux O., Margot P., Gallusser A., Biedermann A., Specht Y., Ottinger E. Forensic drug intelligence: an important tool in law enforcement. Forensic Sci. Int. 2007, 167:247-254.
25. Dujourdy L., Dufey V., Besacier F., Miano N., Marquis R., Lock E., Aalberg L., Dieckmann S., Zrcek F., Bozenko J.S. Drug intelligence based on organic impurities in illicit MA samples. Forensic Sci. Int. 2008, 177:153-161.
26. Lociciro S., Esseiva P., Hayoz P., Dujourdy L., Besacier F., Margot P. Cocaine profiling for strategic intelligence, a cross-border project between France and Switzerland. Part II. Validation of the statistical methodology for the profiling of cocaine. Forensic Sci. Int. 2008, 177:199-206.
27. Esseiva P., Dujourdy L., Anglada F., Taroni F., Margot P. A methodology for illicit heroin seizures comparison in a drug intelligence perspective using large databases. Forensic Sci. Int. 2003, 132:139-152.
28. Ehleringer J.R., Casale J.F., Lott M.J., Ford V.L. Tracing the geographical origin of cocaine. Nature 2000, 408:311-312.
29. Palhol F., Lamoureux C., Chabrillat M., Naulet N. 15N/14N isotope ratio and statistical analysis: an efficient way of linking seized Ecstasy tablets. Anal. Chim. Acta 2004, 510:1-8.
30. Gentile N., Siegwolf R., Delémont O. Study of isotopic variations in black powder: reflection on the use of stable isotopes in forensic science for source inference. Rapid Commun. Mass Spectrom. 2009, 23:2559-2567.
31. Saudan C., Augsburger M., Mangin P., Saugy M. Carbon isotopic ratio analysis by gas chromatography/combustion/isotope ratio mass spectrometry for the detection of gamma-hydroxybutyric acid (GHB) administration to humans. Rapid Commun. Mass Spectrom. 2007, 21:3956-3962.
32. Meier-Augenstein W. Applied gas chromatography coupled to isotope ratio mass spectrometry. J. Chromatogr. A 1999, 842:351-371.
33. Schmitt J., Glaser B., Zech W. Amount-dependent isotopic fractionation during compound-specific isotope analysis. Rapid Commun. Mass Spectrom. 2003, 17:970-977.
34. Lock C.M., Meier-Augenstein W. Investigation of isotopic linkage between precursor and product in the synthesis of a high explosive. Forensic Sci. Int. 2008, 179:157-162.
35. NicDaeid N., Meier-Augenstein W. Feasibility of source identification of seized street drug samples by exploiting differences in isotopic composition at natural abundance level by GC/MS as compared to isotope ratio mass spectrometry (IRMS). Forensic Sci. Int. 2008, 174:259-261.
36. Baertchi P., Kuhn W., Kuhn H. Fractionation of isotopes by distillation of some organic substances. Nature 1953, 171:1018-1020.
37. Bradley D.C. Fractionation of isotopes by distillation of some organic substances. Nature 1954, 173:260-261.
38. Yeh H.-W., Epstein S. Hydrogen and carbon isotopes of petroleum and related organic matter. Geochim. Cosmochim. Acta 1981, 45:753-762.
39. 13C values for biogenic gases in China. Org. Geochem. 2004, 35:405-411.
40. Rieley G. Derivatization of organic compounds prior to gas chromatography-combustion-isotope ratio mass spectrometry analysis: identification of isotope fractionation processes. Analyst 1994, 119:915-919.